We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current IVRN market cap is 3.92k. The company's latest EPS is USD -14.4505 and P/E is 0.00.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 818k | 8.35M | 2.15M | 1.61M | 453k |
| Operating Income | -4.69M | -15.05M | -5.94M | -5.19M | -5.1M |
| Net Income | -5.48M | -33.2M | -5.31M | -4.8M | -10.3M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 404k | 3.27M | 2.2M | 321k | 137k |
| Total Liabilities | 2.4M | 6.67M | 3.25M | 4.98M | 9.49M |
| Total Equity | -2M | -9.46M | -1.05M | -4.66M | -9.36M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.34M | -12.29M | -7.26M | -4.81M | -1.91M |
| Investing | 150k | -393k | -2k | -8k | N/A |
| Financing | 1.99M | 14.04M | 7.48M | 3.27M | 1.82M |
| Market Cap | 3.92k |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0.02 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 712.71k |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 17.82k |
| 52 Week Change | -99.45% |
| 52 Week High | 1.50 |
| 52 Week Low | 0.0003 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Innoveren Scientific Inc (CE) |
| Address |
701 s carson st carson city, nevada 89701 |
| Website | https://www.hcyte.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
